Thromboelastography Analyzer Global Market Report 2026

A thromboelastography analyzer is a medical diagnostic device that assesses the coagulation properties of a patient's blood in real time. It helps to provide a comprehensive evaluation of clot formation, strength, and stability, helping clinicians guide transfusions and manage bleeding or thrombotic disorders. The analyzer measures clotting kinetics using viscoelastic methods, offering detailed insights into platelet function, fibrinogen activity, and overall hemostatic status.

The primary types of thromboelastography analyzers include single and double channel, four channel, and other types. Single and double channel analyzers refer to devices designed to assess the viscoelastic properties of blood in one or two simultaneous channels, providing fast and accurate coagulation analysis. These analyzers use consumables and accessories such as disposable test cartridges, reagent kits, sample cups, pipettes, quality control materials, blood collection tubes, and analyzer accessories and cables. They utilize technologies including conventional thromboelastography, rotational thromboelastometry, and other viscoelastic hemostatic assay technologies. The applications involved include cardiovascular surgery, trauma and emergency care, transplant surgery, obstetrics and gynecology, and liver and hematologic disorders and are used by end users such as hospitals and surgical centers, diagnostic laboratories, maternal and child health services, and other end users.

Tariffs are impacting the thromboelastography analyzer market by increasing the cost of imported diagnostic instruments, electronic components, reagents, and disposable consumables, which raises procurement and operational expenses for hospitals and laboratories. Regions heavily dependent on foreign medical device imports, particularly parts of Asia-Pacific and Latin America, experience stronger pricing pressures. Hardware-intensive segments such as multi-channel analyzers and advanced viscoelastic systems are the most affected. However, tariffs are also encouraging domestic medical device manufacturing, local reagent production, and regional research investments, which can strengthen long-term supply chain resilience and technological self-reliance.

The thromboelastography analyzer market size has grown rapidly in recent years. It will grow from $0.41 billion in 2025 to $0.45 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing prevalence of bleeding disorders, rising number of surgical procedures, growth in trauma and emergency cases, expansion of hospital infrastructure, increasing awareness of blood coagulation diagnostics.

The thromboelastography analyzer market size is expected to see rapid growth in the next few years. It will grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to growing demand for personalized medicine approaches, rising investment in advanced diagnostic technologies, increasing geriatric population, expansion of critical care facilities, demand for rapid bedside testing solutions. Major trends in the forecast period include rising adoption of point of care coagulation testing, growth in multi-channel high throughput analyzers, increasing demand for surgical and trauma hemostasis monitoring, expansion of disposable reagents and consumables usage, integration of comprehensive blood clotting assessment in critical care.

The increasing prevalence of trauma and emergency care cases is anticipated to drive the growth of the thromboelastography analyzer market in the coming years. Trauma and emergency care cases refer to acute medical situations involving severe injuries or sudden life-threatening conditions that require immediate medical intervention to prevent mortality or long-term disability. Trauma and emergency care cases are rising due to factors such as the growing incidence of road traffic accidents. The surge in road traffic accidents is accelerating demand for thromboelastography analyzers, as these devices enable rapid assessment of coagulation status in trauma patients, allowing timely bleeding control and improving emergency care outcomes. For instance, in September 2025, according to the National Health Services, a UK-based government health agency, there were 27.4 million accident and emergency attendances in 2024-25, reflecting an increase of 4.0% compared with 2023-24. Therefore, the rising prevalence of trauma and emergency care cases is driving the growth of the thromboelastography analyzer market.

The increasing number of surgical procedures is anticipated to propel the growth of the thromboelastography analyzer market in the coming years. The growing number of surgical procedures refers to the rising volume of elective, emergency, and minimally invasive operations performed to diagnose, treat, or manage medical conditions. Surgical volumes are expanding as aging populations are increasing the prevalence of chronic diseases that require operative intervention. Thromboelastography analyzers facilitate the expanding volume of surgical procedures by providing real-time coagulation assessment, which helps clinicians manage bleeding risk and optimize transfusion decisions during complex and high-throughput surgeries. For instance, in May 2024, according to NHS England, a UK-based public health authority, elective surgical admissions increased from $0.0169 billion in 2022-2023 to $0.0171 billion in 2023-2024, indicating continued growth in surgical activity across the national healthcare system. Therefore, the growing number of surgical procedures is contributing the growth of the thromboelastography analyzer market.

Key companies operating in the thromboelastography analyzer market are focusing on developing innovative products, such as extended-use assay cartridges for viscoelastic testing systems, to enable broader clinical application and faster, more comprehensive coagulation profiling across diverse patient groups. Extended-use assay cartridges for viscoelastic testing systems refer to consumable testing modules designed to expand the diagnostic capabilities of thromboelastography analyzers by catering to specific clinical conditions and patient cohorts. For example, in April 2024, Haemonetics Corporation, a US-based provider of medical technologies and solutions for blood management, announced U.S. Food and Drug Administration (FDA) approval for its TEG 6s Global Hemostasis. This cartridge received FDA 510(k) clearance to extend the system's viscoelastic testing capabilities to fully heparinized patients undergoing adult cardiovascular surgeries and liver transplantation, enhancing its use in both laboratory and point-of-care settings. The Global Hemostasis-HN cartridge provides clinicians with comprehensive insights into a patient's coagulation profile faster and with greater detail than conventional tests, supported by software that enables remote real-time result viewing and customizable alerts. This innovation supports more informed treatment decisions in critical care scenarios where rapid, accurate hemostasis assessment is essential.

Major companies operating in the thromboelastography analyzer market are Medtronic plc, Werfen SA, Haemonetics Corporation, Lepu Medical Technology (Beijing) Co. Ltd, Helena Laboratories Corporation, Zircon Corp., Diagnostica Stago Inc., Hemosonics LLC, Chongqing Nanfang Instruments Co. Ltd., Medcaptain Medical Technology Co. Ltd., Render Biotech Co. Ltd., Sienco Inc., Framer Hemologix-Srl, Biomart Inc., Guizhou Jinjiu Biotech Co. Ltd., Xenometrix AG, Zhejiang Shengyu Medical Instrument Co. Ltd., Beijing WITEYE Biotechnology Co. Ltd., UD-BIO, Beijing Succeeder Technology Inc., Sycomed E.K.

North America was the largest region in the thromboelastography analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thromboelastography analyzer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the thromboelastography analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thromboelastography analyzer market consists of sales of thromboelastography analyzers, viscoelastic coagulation testing systems, point-of-care hemostasis analyzers, laboratory-based thromboelastography (TEG) instruments, and thromboelastography (TEG) reagents and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The thromboelastography analyzer market research report is one of a series of new reports from The Business Research Company that provides thromboelastography analyzer market statistics, including thromboelastography analyzer industry global market size, regional shares, competitors with a thromboelastography analyzer market share, detailed thromboelastography analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the thromboelastography analyzer industry. This thromboelastography analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Thromboelastography Analyzer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses thromboelastography analyzer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for thromboelastography analyzer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thromboelastography analyzer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Single And Double Channel; Four Channels; Other Types
• 2) By Consumables Or Accessories: Disposable Test Cartridges; Reagent Kits; Sample Cups; Pipettes; Quality Control Materials; Blood Collection Tubes; Analyzer Accessories And Cables
• 3) By Technology: Conventional Thromboelastography (TEG); Rotational Thromboelastometry (ROTEM); Other Viscoelastic Hemostatic Assay (VHA) Technologies
• 4) By Application: Cardiovascular Surgery; Trauma And Emergency Care; Transplant Surgery; Obstetrics And Gynecology; Liver And Hematologic Disorders
• 5) By End-User: Hospitals And Surgical Centers; Diagnostic Laboratories; Maternal And Child Health Services; Other End-Users
• Subsegments:
• 1) By Single And Double Channel: Single Sample Analysis; Dual Sample Analysis; Routine Coagulation Testing; Point Of Care Usage
• 2) By Four Channels: Multi Sample Parallel Analysis; High Throughput Testing; Advanced Clinical Diagnostics; Critical Care Monitoring
• 3) By Other Types: Portable Thromboelastography Systems; Research Oriented Systems; Customized Diagnostic Configurations
• Companies Mentioned: Medtronic plc; Werfen SA; Haemonetics Corporation; Lepu Medical Technology (Beijing) Co. Ltd; Helena Laboratories Corporation; Zircon Corp.; Diagnostica Stago Inc.; Hemosonics LLC; Chongqing Nanfang Instruments Co. Ltd.; Medcaptain Medical Technology Co. Ltd.; Render Biotech Co. Ltd.; Sienco Inc.; Framer Hemologix-Srl; Biomart Inc.; Guizhou Jinjiu Biotech Co. Ltd.; Xenometrix AG; Zhejiang Shengyu Medical Instrument Co. Ltd.; Beijing WITEYE Biotechnology Co. Ltd.; UD-BIO; Beijing Succeeder Technology Inc.; Sycomed E.K.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.